Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

24%

4 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed with results

Key Signals

3 with results90% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (9)
Early P 1 (1)
P 4 (4)

Trial Status

Completed9
Active Not Recruiting3
Unknown2
Recruiting1
Terminated1
Enrolling By Invitation1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT05657106Not ApplicableActive Not Recruiting

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

NCT03567174Not ApplicableCompletedPrimary

Building on Needle Exchange to Optimize Prevention & Treatment

NCT06103370Not ApplicableRecruiting

Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

NCT03981445Not ApplicableActive Not Recruiting

Integrated HIV Prevention and HCV Care for PWID

NCT05739071Not ApplicableEnrolling By Invitation

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

NCT03523533Not ApplicableTerminatedPrimary

Peripherally Inserted Internal Jugular Catheters: an Observational Study

NCT04943432Not ApplicableCompletedPrimary

Open Trial of a Behavioral Activation Telepsychology Intervention for People Who Inject Drugs

NCT04714112Phase 4Completed

Low-dose Intravenous Dexamethasone at Different Times as Adjunvants for Brachial Plexus Blocks

NCT05695664Early Phase 1CompletedPrimary

Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery

NCT05647408Not ApplicableCompleted

Evaluation of the Bioavailability of Dexamethasone in Healthy Subjects

NCT03993925Active Not Recruiting

Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong

NCT04432233Phase 4Unknown

Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease

NCT04304157Phase 4CompletedPrimary

Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia

NCT03927118Completed

Effect of Dexamethasone Implant on Optic Disc

NCT02999217Phase 4Unknown

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

NCT01831284CompletedPrimary

Correlates and Consequences of Increased Immune Activation in Injection Drug Users

NCT01477905Not ApplicableCompletedPrimary

Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of Remifentanil

Showing all 17 trials

Research Network

Activity Timeline